Featured News by Tag: FastTRK
Featured News
On March 31, 2025, LifeLabs Genetics will complete the FastTRK Testing Program funded by Bayer Inc. We will continue to offer NTRK fusion testing as part of our molecular pathology services, including...
September
2
2020
LifeLabs partners with Bayer Inc. to offer clinicians a complimentary testing service to detect TRK fusion cancer
PRESS RELEASE—Toronto, ON (September 2, 2020) – LifeLabs is pleased announce it has partnered with Bayer Inc. to launch FastTRK, a complimentary clinical testing program for the diagnosis of neuro...